Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products.

Lapi F, Gallo E, Bernasconi S, Vietri M, Menniti-Ippolito F, Raschetti R, Gori L, Firenzuoli F, Mugelli A, Vannacci A.

Br J Clin Pharmacol. 2008 Oct;66(4):572-4. doi: 10.1111/j.1365-2125.2008.03224.x. Epub 2008 May 21. No abstract available.

2.

The role of red yeast rice for the physician.

Gordon RY, Becker DJ.

Curr Atheroscler Rep. 2011 Feb;13(1):73-80. doi: 10.1007/s11883-010-0145-0. Review.

PMID:
21061097
3.

[With red rice against cholesterol?].

Enkovaara AL.

Duodecim. 2010;126(6):623-6. Review. Finnish.

PMID:
20597312
4.
5.

Liquorice and its health implications.

Olukoga A, Donaldson D.

J R Soc Promot Health. 2000 Jun;120(2):83-9. Review.

PMID:
10944880
6.

Red yeast rice: a new hypolipidemic drug.

Journoud M, Jones PJ.

Life Sci. 2004 Apr 16;74(22):2675-83. Review.

PMID:
15069955
7.

'Muscle-sparing' statins: preclinical profiles and future clinical use.

Pfefferkorn JA.

Curr Opin Investig Drugs. 2009 Mar;10(3):245-52. Review.

PMID:
19333882
8.

[Necrotizing myopathies].

Kumamoto T.

Ryoikibetsu Shokogun Shirizu. 2001;(36):239-42. Review. Japanese. No abstract available.

PMID:
11596379
9.

Toxic and drug-induced myopathies.

Dalakas MC.

J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):832-8. doi: 10.1136/jnnp.2008.168294. Review.

PMID:
19608783
10.

Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.

MacDonald L, Murty M, Foster BC.

Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):563-78. doi: 10.1517/17425250902942302. Review.

PMID:
19442034
11.

Emerging toxic neuropathies and myopathies.

Kushlaf HA.

Neurol Clin. 2011 Aug;29(3):679-87. doi: 10.1016/j.ncl.2011.05.009. Epub 2011 Jul 14. Review.

PMID:
21803218
12.

How do you treat patients with myalgia who take statins?

Siddiqi SA, Thompson PD.

Curr Atheroscler Rep. 2009 Jan;11(1):9-14. Review.

PMID:
19080722
13.

High-dose statin therapy: benefits and safety in aggressive lipid lowering.

Toth PP, Davidson MH.

J Fam Pract. 2008 May;57(5 Suppl High-Dose):S29-36. Review. No abstract available.

PMID:
18662521
14.

Aches and pains--is your statin to blame. Muscle pain is the most common side effect of cholesterol-lowering statins.

[No authors listed]

Harv Heart Lett. 2008 Sep;19(1):3. Review. No abstract available.

PMID:
18946915
15.

[Statins and neuromuscular pathology].

Turpin-Fenoll L, Millan-Pascual J, Martin-Estefania C.

Rev Neurol. 2008 Jul 1-15;47(1):46-51. Review. Spanish.

16.

Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality.

Liberopoulos EN, Florentin M, Mikhailidis DP, Elisaf MS.

Expert Opin Drug Saf. 2008 Nov;7(6):717-25. doi: 10.1517/14740330802396984 . Review.

PMID:
18983218
17.

Drug-induced liver injury associated with statins.

Russo MW, Scobey M, Bonkovsky HL.

Semin Liver Dis. 2009 Nov;29(4):412-22. doi: 10.1055/s-0029-1240010. Epub 2009 Oct 13. Review.

PMID:
19826975
18.

Statin myopathy as a metabolic muscle disease.

Phillips PS, Haas RH.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):971-8. doi: 10.1586/14779072.6.7.971. Review.

PMID:
18666847
19.

Managing statin myopathy.

Venero CV, Thompson PD.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):121-36. doi: 10.1016/j.ecl.2008.11.002. Review.

PMID:
19217515
20.

Cosmeceuticals and natural products: wound healing.

Davis SC, Perez R.

Clin Dermatol. 2009 Sep-Oct;27(5):502-6. doi: 10.1016/j.clindermatol.2009.05.015. Review.

PMID:
19695483
Items per page

Supplemental Content

Write to the Help Desk